| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8216056 | International Journal of Radiation Oncology*Biology*Physics | 2015 | 34 Pages |
Abstract
TN patients had the highest risk of LRR and the least benefit from PMRT; these patients may benefit from alternative treatment strategies. In contrast, in the era of HER2-directed therapy, the role of local therapy may need to be reassessed among HER2 patients.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Yolanda D. MD, Hajime PhD, Melissa E. MSc, Joyce C. PhD, Yu-Ning MD, Richard MD, Rachel C. MD, PhD, Beverly MD, MPH, Tara MD, Stephen B. MD, Michael J. MD, MPH, Rinaa S. MD, MPH,